Chargement en cours...
Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies
BACKGROUND: Rituximab (RTX), a monoclonal antibody that selectively binds to CD20+ B cells, showed favorable outcomes in patients with idiopathic inflammatory myopathies (IIM) in small case series, but the evidence is still not enough. Our goal was to determine the efficacy and safety of RTX for Kor...
Enregistré dans:
| Publié dans: | J Korean Med Sci |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Korean Academy of Medical Sciences
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7521958/ https://ncbi.nlm.nih.gov/pubmed/32989931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e335 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|